Date : 10-11 September 2015
Location : San Diego (USA)
View the link8 July 2015
- 8 July 2015
Paris, France – 20 April 2015 Enterome is looking for a Bioinformatics Platform Manager See the Job Description20 April 2015
Paris, France – 16 April 2015 Microbiome sets off a rush among developers Pierre Belichard, CEO of Enterome, interviewed...16 April 2015
Who we are
Measurement and modulation of the gut microbiome in health and disease presents the opportunity to impact medicine in an entirely new and unexplored way.
Enterome is pioneering the development of novel drugs and diagnostics to support personalized therapies in microbiome-related diseases such as Inflammatory Bowel Diseases (IBD), metabolic diseases, and related disorders.
Enterome is also leading the development of new industry standards in gut microbiome quantitative and functional analysis. Opening up a new field of therapeutic targets discovery in the microbiome and allowing the innovative repositioning of existing compounds targeting this new organ.